U.S. markets closed
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • Dow 30

    34,479.60
    +13.36 (+0.04%)
     
  • Nasdaq

    14,069.42
    +49.09 (+0.35%)
     
  • Russell 2000

    2,335.81
    +24.40 (+1.06%)
     
  • Crude Oil

    70.78
    +0.49 (+0.70%)
     
  • Gold

    1,879.50
    -16.90 (-0.89%)
     
  • Silver

    28.05
    +0.02 (+0.07%)
     
  • EUR/USD

    1.2107
    -0.0071 (-0.58%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • GBP/USD

    1.4117
    -0.0060 (-0.42%)
     
  • USD/JPY

    109.6350
    +0.2870 (+0.26%)
     
  • BTC-USD

    35,928.62
    -928.84 (-2.52%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • Nikkei 225

    28,948.73
    -9.83 (-0.03%)
     

Should You Be Tempted To ‘Sell’ Silk Road Medical (SILK) Stock

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

Wasatch Micro Cap Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 31.3% for the quarter, underperforming its benchmark, the Russell Microcap Index which returned 31.4% in the same quarter. You should check out Wasatch's top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.

In the Q4 2020 Investor Letter, Wasatch highlighted a few stocks and Silk Road Medical Inc (NASDAQ:SILK) is one of them. Silk Road Medical Inc (NASDAQ:SILK) produces and distributes surgical equipment. In the last three months, Silk Road Medical Inc (NASDAQ:SILK) stock lost 2.7% and on February 25th it had a closing price of $54.59. Here is what Wasatch said:

"Another weak stock was Silk Road Medical, Inc. (SILK). The company provides implantable devices for the treatment of carotid-artery disease in highrisk patients. Although revenues in Silk Road’s most recent quarter came in better than expected, investors reacted negatively after management failed to provide new details about the company’s approval pathway for addressing the standard-risk patient market. A lack of new developments regarding Silk Road’s pipeline product for the treatment of ischemic stroke also appeared to weigh on the stock."

Top Cities With Most Breast Implants in US
Top Cities With Most Breast Implants in US

Stoyan Yotov/Shutterstock.com

Earlier this month, we published an article revealing that Baron Discovery Fund is betting on Silk Road Medical Inc (NASDAQ:SILK) stock. The investment firm said that the addressable market for the company is huge.

In Q3 2020, the number of bullish hedge fund positions on Silk Road Medical Inc (NASDAQ:SILK) stock remained unchanged from the previous quarter (see the chart here). Our calculations showed that Silk Road Medical Inc (NASDAQ:SILK) isn't ranked among the 30 most popular stocks among hedge funds.

The top 10 stocks among hedge funds returned 231.2% between 2015 and 2020, and outperformed the S&P 500 Index ETFs by more than 126 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds' poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Here you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.

At Insider Monkey we scour multiple sources to uncover the next great investment idea. For example, Federal Reserve has been creating trillions of dollars electronically to keep the interest rates near zero. We believe this will lead to inflation and boost real estate prices. So, we recommended this real estate stock to our monthly premium newsletter subscribers. We go through lists like the 15 best innovative stocks to buy to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our website:

Disclosure: None. This article is originally published at Insider Monkey.